Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome

X Fan, Y Yoshida, S Honda, M Matsumoto… - Molecular …, 2013 - Elsevier
Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia,
thrombocytopenia, and renal impairment. Approximately 10% of cases are classified as …

Membranous nephropathy: a single disease or a pattern of injury resulting from different diseases

S Sethi - Clinical Kidney Journal, 2021 - academic.oup.com
Membranous nephropathy (MN) is defined as disease entity characterized by thickening of
the glomerular basement membranes due to subepithelial (SE) deposition of immune …

Diagnostic and prognostic comparison of immune-complex-mediated membranoproliferative glomerulonephritis and C3 glomerulopathy

M Kovala, M Seppälä, A Räisänen-Sokolowski, S Meri… - Cells, 2023 - mdpi.com
Membranoproliferative glomerulonephritis (MPGN) is subdivided into immune-complex-
mediated glomerulonephritis (IC-MPGN) and C3 glomerulopathy (C3G). Classically, MPGN …

[HTML][HTML] Hepatitis C and kidney disease: an overview and approach to management

AN Azmi, SS Tan, R Mohamed - World journal of hepatology, 2015 - ncbi.nlm.nih.gov
Hepatitis C infection and chronic kidney disease are major health burden worldwide.
Hepatitis C infection is associated with a wide range of extra-hepatic manifestations in …

Primary glomerulonephritis in mainland China: an overview

J Xie, N Chen - New Insights into Glomerulonephritis, 2013 - karger.com
Chronic kidney disease (CKD) has received increased attention as a global health problem
because of its increasing incidence and prevalence, poor outcome and high associated …

Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment

M Noris, E Daina, G Remuzzi - Nephrology Dialysis …, 2023 - academic.oup.com
Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury that may
be primary or secondary to infections, autoimmune diseases and haematological disorders …

Biologics for the treatment of autoimmune renal diseases

SR Holdsworth, PY Gan, AR Kitching - Nature Reviews Nephrology, 2016 - nature.com
Biological therapeutics (biologics) that target autoimmune responses and inflammatory
injury pathways have a marked beneficial impact on the management of many chronic …

Comprehensive analysis of complement genes in patients with atypical hemolytic uremic syndrome

T Zhang, J Lu, S Liang, D Chen, H Zhang… - American Journal of …, 2016 - karger.com
Background: Genetic defects in complement proteins reportedly contribute to the atypical
hemolytic uremic syndrome (aHUS). Numerous genetic studies have been published in …

Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A …

N Nakagawa, M Mizuno, S Kato, S Maruyama, H Sato… - PLoS …, 2021 - journals.plos.org
The reclassification of membranoproliferative glomerulonephritis (MPGN) into immune-
complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G) based on immunofluorescence …

Nephrotic Syndrome for the internist

MJZ Ramirez, EJ Stein, K Jain - Medical Clinics, 2023 - medical.theclinics.com
Background Nephrotic syndrome (NS) is a disorder of the kidney that is defined by the
presence of greater than 3 to 3.5 g per day of proteinuria, which results in hypoalbuminemia …